期刊文献+

甲磺酸多沙唑嗪控释片的临床应用研究进展 被引量:3

Development on clinical research of cardura
下载PDF
导出
摘要 综述甲磺酸多沙唑嗪控释片(可多华)在治疗高血压和良性前列腺增生(BHP)两个方面的最新临床研究进展。在治疗高血压方面,可多华可引起动脉血管弹性的增加,减少高血压患者血小板的激活;可降低高胆固醇仓鼠血浆中的TC,LDL-C和TG,并可改善对胰岛素的抵抗。在治疗良性前列腺增生方面,通过一种未知的机制抑制ATP的释放,增加膀胱的血流量,并可以改善BPH患者的性功能。 Cardura (doxazosin mesylate) is used to treat both benign prostatic hyperplasia (BPH) and high blood pressure (hypertension). It relieves the symptoms of BPH by relaxing the muscles of the bladder and prostate. It also inhibits ATP release by an unknown mechanism, increases blood flow to the bladder and improves sexual function in patients with BPH. The mechanism of action of blood pressure is by relaxing the blood vessels so that blood can flow more easily through the body. In addtion, it increases arterial elasticity, has a positive effect on platelet activation, decreases the TC, LDL-C, TG and hypercholesterolemic hamsters and improves the insulin resistance in adults with hypertension. This paper summarizes the latest clinical applications of cardura.
出处 《中国新药杂志》 CAS CSCD 北大核心 2006年第8期595-597,共3页 Chinese Journal of New Drugs
关键词 甲磺酸多沙唑嗪控释片 高血压 良性前列腺增生 doxazosin hypertension benign prostatic hyperplasia (BPH)
  • 相关文献

参考文献13

  • 1GRZESZCZAK W,CARDURA XL.A unique drug formulationdoxazosine administered in a slow-release form (doxazosine GITS)[J].Przegl Lek,2000,57(11):643 -654.
  • 2JIMENEZ-GARCIA R,ANEGON M,ESTEBAN J,et al.Safety and effectiveness of replacing standard doxazosin with doxazosin in the gastrointestinal therapeutic system (GITS) formulation in elderly bypertensive patients[J].Int J Clin Pract,2003,57 (4):267-272.
  • 3ANEGON M,ESTEBAN J.JIMENEZ-GARCIA R,et al.A postmarketing,open-label study to evaluate the tolerability and effectiveness of replacing standard-formulation doxazosin with doxazosin in the gastrointestinal therapeutic system formulation in adult patients with hypertension[J].Clin Ther,2002,24 (5):786-797.
  • 4BRATTELI CW,GLASSER SP.Effect of doxazosin on arterial elasticity:functional versus structural changes[J].J Clin Pharmacol,2002,42 (10):1105-1108.
  • 5LABIOS M,MARTINEZ M,GABRIEL F,et al.Flow cytometric analysis of platelet activation in hypertensive patients.Effect of doxazosin[J].Thromb Res,2003,110(4):203 -208.
  • 6WILSON TA,FOXALL TL,NICOLOSI RJ.Doxazosin,an alpha-1 antagonist,prevents further progression of the advanced atherosclerotic lesion in hypercholesterolemic hamsters[J].Metabolism,2003,52(10):1240-1245.
  • 7UESHIBA H,MIYACHI Y.Effect of doxazosin on insulin resistance in hypertensive patients with obesity[J],Horm Metab Res,2003,35(9):532 -536.
  • 8COURTNEY CH,MCCANCE DR,ATKINSON AB,et al.Effect of the alpha-adrenergic blocker,doxazosin,on endothelial function and insulin action[J].Metabolism,2003,52 (9):1147-1452.
  • 9ANDERSEN M,DAHLSTRAND C,HOYE K.Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system,doxazosin standard,and placebo in patientswith benign prostatic hyperplasia[J].Eur Urol,2000,38 (4):400-409.
  • 10SUN Y,MALOSSI J,JACOBS SC,et al.Effect of doxazosin on stretch-activated adenosine triphosphate release in bladder urothelial cells from patients with benign prostatic hyperplasia[J].Urology,2002,60(2):351 -356.

同被引文献33

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部